We are live on ! Find out more
XLO icon

Xilio Therapeutics
XLO

42 hedge funds and large institutions have $303M invested in Xilio Therapeutics in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5.09% more ownership

Funds ownership: 0% → 5.09% (+5.1%)

Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
0.65%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
42
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$47.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.8M
3
DM
Deerfield Management
New York
+$36.7M
4
RCM
RA Capital Management
Massachusetts
+$34.1M
5
RVM
RiverVest Venture Management
Missouri
+$24.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$187K +$199K +835 New
N
27
Nuveen
North Carolina
$181K +$192K +806 New
GPCM
28
Granite Point Capital Management
Massachusetts
$160K +$170K +714 New
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$89K +$94.9K +398 New
Bank of America
30
Bank of America
North Carolina
$76K +$81.3K +341 New
Deutsche Bank
31
Deutsche Bank
Germany
$72K +$76.8K +322 New
Wells Fargo
32
Wells Fargo
California
$71K +$76.1K +319 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$65K +$69.4K +291 New
UBS Group
34
UBS Group
Switzerland
$64K +$67.7K +284 New
AIG
35
American International Group
New York
$63K +$67.2K +282 New
Citigroup
36
Citigroup
New York
$35K +$37.4K +157 New
SO
37
STRS Ohio
Ohio
$27K +$28.9K +121 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$25K +$26.9K +113 New
Morgan Stanley
39
Morgan Stanley
New York
$17K +$17.6K +74 New
TRCT
40
Tower Research Capital (TRC)
New York
$15K +$16.5K +69 New
Legal & General Group
41
Legal & General Group
United Kingdom
$11K +$11.9K +50 New
AIP
42
Ameritas Investment Partners
Nebraska
$9K +$9.78K +41 New
1
2

XLO Hedge Fund Activity: Q4 2021 in Review

42 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Xilio Therapeutics (XLO) for Q4 2021, worth a combined $303M.

Buyers outnumbered sellers: 42 funds opened new XLO positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $47.8M.

  • 42 institutional investors held Xilio Therapeutics (XLO) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $303M of Xilio Therapeutics stock for Q4 2021.
  • 42 funds opened new Xilio Therapeutics positions in Q4 2021 and 0 closed out, a net change of +42 holders.
  • The largest Xilio Therapeutics buyer in Q4 2021 was Bain Capital Life Sciences Investors, an estimated $47.8M added.

Based on aggregated 13F filings for Q4 2021.